Authors: Boyle, CD Chackalamannil, S Clader, JW Greenlee, WJ Josien, HB Kaminski, JJ Kozlowski, JA McCombie, SW Nazareno, DV Tagat, JR Wang, YG Zhou, GW Billard, W Binch, H Crosby, G Cohen-Williams, M Coffin, VL Cox, KA Grotz, DE Duffy, RA Ruperto, V Lachowicz, JE

Citation: Cd. Boyle et al., Metabolic stabilization of benzylidene ketal M-2 muscarinic receptor antagonists via halonaphthoic acid substitution, BIOORG MED, 11(17), 2001, pp. 2311-2314

Authors: Lachowicz, JE Duffy, RA Ruperto, V Kozlowski, J Zhou, GW Clader, J Billard, W Binch, H Crosby, G Cohen-Williams, M Strader, CD Coffin, V

Citation: Je. Lachowicz et al., Facilitation of acetylcholine release and improvement in cognition by a selective M-2 muscarinic antagonist, SCH 72788, LIFE SCI, 68(22-23), 2001, pp. 2585-2592

Authors: Carey, GJ Billard, W Binch, H Cohen-Williams, M Crosby, G Grzelak, M Guzik, H Kozlowski, JA Lowe, DB Pond, AJ Tedesco, RP Watkins, RW Coffin, VL

Citation: Gj. Carey et al., SCH 57790, a selective muscarinic M-2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals, EUR J PHARM, 431(2), 2001, pp. 189-200

Authors: Varty, GB Walters, N Cohen-Williams, M Carey, GJ

Citation: Gb. Varty et al., Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains, EUR J PHARM, 424(1), 2001, pp. 27-36

Authors: Boyle, CD Chackalamannil, S Chen, LY Dugar, S Pushpavanam, P Billard, W Binch, H Crosby, G Cohen-Williams, M Coffin, VL Duffy, RA Ruperto, V Lachowicz, JE

Citation: Cd. Boyle et al., Benzylidene ketal derivatives as M-2 muscarinic receptor antagonists, BIOORG MED, 10(24), 2000, pp. 2727-2730